An Act establishing a commission to study the promotion of preferred pharmacy networks

HD 2249 establishes a commission to study how health insurers use "preferred pharmacy networks" to steer patients toward lower-cost pharmacies where insurers negotiate better drug prices. The commission, composed of legislative leaders, health officials, and policy experts, will analyze the feasibility and cost-benefit of implementing such networks and estimate potential prescription drug savings. It must submit a report with recommendations and draft legislation to relevant committees within 12 months of the bill's passage. This bill does not change current law but creates a formal process to evaluate a specific cost-saving approach used by insurers. The direct effect is on insurers, pharmacies, and the state's health policy decision-makers.